McLean Hospital 115 Mill Street Belmont, MA 02478
McLean Borden Cottage, scheduled to open in early 2015 in Camden, Maine, is the hospital's new residential treatment program for drug and alcohol addiction and the first McLean program to open outside of Massachusetts.
Set on nearly 14 acres of lawns and gardens and overlooking Penobscot Bay, Borden Cottage is modeled clinically after McLean's other off-campus programs and will be "fully integrated into the McLean alcohol and drug abuse treatment program and an integral part of the hospital," said Philip G. Levendusky, PhD, ABPP, senior vice president for Business Development and Communications and director of the Psychology Department and co-director of Psychology Training at McLean Hospital.
As with all of McLean's programs, Borden Cottage provides evidence-based treatment modalities for alcohol and drug addiction. Led by clinicians who are experts in the use of pioneering medications and behavioral treatments, the goal is for patients to achieve and maintain abstinence and learn how to manage the stresses of an active life without returning to alcohol or drugs. The seven-day-a-week program focuses on recovery and relapse prevention, and a 30-day minimum stay assures full benefit from the program. Also provided is hands-on support and education for family members and significant others about drug and alcohol addiction and close collaboration with referrers and community providers.
"McLean recognizes the tremendous need for high-quality mental health and substance abuse care and we are continuing to explore opportunities for expanding our programs to different areas of the country," said Levendusky. "We want to broaden our access to people nationally and internationally."
Hilary S. Connery, MD, PhD, clinical director of McLean's Division of Alcohol and Drug Abuse and an assistant professor of Psychiatry at Harvard Medical School, said the opening of Borden Cottage is an exciting opportunity for extending McLean's model of care to other populations.
"Part of the mission of the hospital is to provide the highest quality of evidence-based clinical care for substance use disorders and co-occurring mental health conditions,” said Connery. “We have a model of integrated care that's very effective.”
Roger D. Weiss, MD, chief of McLean Hospital's Division of Alcohol and Drug Abuse and a Professor of Psychiatry at Harvard Medical School added that Borden Cottage will follow the lead of other successful McLean programs.
"The Division of Alcohol and Drug Abuse has experienced great success in running programs that are located off of the hospital’s main campus—the Fernside program in Princeton, Mass, and the Naukeag program in Ashburnham, Mass. Each has been open for a number of years and they have been thoroughly integrated with our on-campus programs and offer the same level of care, the guiding treatment philosophy, and types of evidenced-based treatments."
Frederick Goggans, MD, who was selected to serve as medical director for Borden Cottage, said the new program will have a positive impact on the Camden area.
"The presence of this facility will lead to a greater emphasis on the importance of treating addictive disease and will improve professional education and general understanding in the community regarding recovery from these disorders," he said.
Recently named a Distinguished Life Fellow of the American Psychiatric Association, Goggans is the chairman of the Department of Psychiatry at Pen Bay Medical Center. He will focus not only the medical director position but also his role as associate psychiatrist at McLean and lecturer in psychiatry at Harvard Medical School. He will also continue to provide outpatient addiction services at Pen Bay on a part-time basis and will also assist the center in enhancing its addiction services programs.
As medical director, Goggans will be responsible for oversight of all medical, psychiatric, and substance abuse treatment, as well as the oversight of quality of care and supervision of all licensed personnel and the development of a consulting medical staff.
"Borden Cottage will probably spark programs in the mid-coast Maine region to help serve the local population," said Goggans. "McLean could provide a source of ongoing education and support for the healthcare community."
Nancy Merrill, PMHCNS,BC, who oversees the management of the programs at Fernside and Naukeag and was instrumental in their development as well as program development for Borden Cottage, said, "This is a great opportunity to be able to bring our services to another location. As a team, we're excited about replicating McLean's knowledge and expertise outside of Massachusetts.”
Merrill is currently working with her department to hire clinicians, nurses, community resident counselors, case managers, therapists, and a program director. Most of the staff hired so far is from the Camden area, she said.
"We want to hire as much local talent as we can," said Levendusky, adding that Borden Cottage will have a "significant and positive economic influence in the mid-coast Maine region, with McLean being a year-round employer as well as an active contributing member of the community."